Germs 101 (infographic)
Bridging the Gap: Community-Based Organizations Seek Trust, Tools and Funding to Advance Public Health
Community-based organizations (CBOs) are the cornerstone of community health—yet across the country they face substantial uncertainty, according to a new national survey supported by the Pfizer Multicultural Health Equity Collective (The Collective).
Bridging the Gap: Community-Based Organizations Seek Trust, Tools and Funding to Advance Public Health
Community-based organizations (CBOs) are the cornerstone of community health—yet across the country they face substantial uncertainty, according to a new national survey supported by the Pfizer Multicultural Health Equity Collective (The Collective).
Pursuing the Next Breakthrough in Cancer Cachexia
Cachexia, a complex wasting syndrome, impacts an estimated 9 million people worldwide. Currently, there are no FDA-approved treatments targeting its underlying cause.
Pursuing the Next Breakthrough in Cancer Cachexia
Cachexia, a complex wasting syndrome, impacts an estimated 9 million people worldwide. Currently, there are no FDA-approved treatments targeting its underlying cause.
Brighter Together: How the Pharmaceutical Industry is Shining a Light on a Rare Cause of Heart Failure
Among the lesser known causes of heart failure is transthyretin amyloid cardiomyopathy (ATTR-CM). Early suspicion and diagnosis are crucial. That’s why Pfizer is working with other industry partners as part of the ASPIRE group, led by Amyloidosis Research Consortium (ARC), to accelerate earlier detection and diagnosis.
Brighter Together: How the Pharmaceutical Industry is Shining a Light on a Rare Cause of Heart Failure
Among the lesser known causes of heart failure is transthyretin amyloid cardiomyopathy (ATTR-CM). Early suspicion and diagnosis are crucial. That’s why Pfizer is working with other industry partners as part of the ASPIRE group, led by Amyloidosis Research Consortium (ARC), to accelerate earlier detection and diagnosis.
You’ve Still Got It: Aging with Agency to Stay on Top of Your Health Year-Round
Aamir Malik is Executive Vice President, Chief U.S. Commercial Officer, Pfizer Inc. Today, he writes about the importance of taking control of your health as you age.
You’ve Still Got It: Aging with Agency to Stay on Top of Your Health Year-Round
Aamir Malik is Executive Vice President, Chief U.S. Commercial Officer, Pfizer Inc. Today, he writes about the importance of taking control of your health as you age.
Developing a Path Forward in Cancer Cachexia
Across disciplines, therapeutic areas, and even continents, Pfizer scientists have been working to advance understanding of – and potential treatments for – cachexia, a complex metabolic condition associated with certain chronic conditions.
Developing a Path Forward in Cancer Cachexia
Across disciplines, therapeutic areas, and even continents, Pfizer scientists have been working to advance understanding of – and potential treatments for – cachexia, a complex metabolic condition associated with certain chronic conditions.
Bridging the Gap: Community-Based Organizations Seek Trust, Tools and Funding to Advance Public Health
Community-based organizations (CBOs) are the cornerstone of community health—yet across the country they face substantial uncertainty, according to a new national survey supported by the Pfizer Multicultural Health Equity Collective (The Collective).
Bridging the Gap: Community-Based Organizations Seek Trust, Tools and Funding to Advance Public Health
Community-based organizations (CBOs) are the cornerstone of community health—yet across the country they face substantial uncertainty, according to a new national survey supported by the Pfizer Multicultural Health Equity Collective (The Collective).
Pursuing the Next Breakthrough in Cancer Cachexia
Cachexia, a complex wasting syndrome, impacts an estimated 9 million people worldwide. Currently, there are no FDA-approved treatments targeting its underlying cause.
Pursuing the Next Breakthrough in Cancer Cachexia
Cachexia, a complex wasting syndrome, impacts an estimated 9 million people worldwide. Currently, there are no FDA-approved treatments targeting its underlying cause.
Brighter Together: How the Pharmaceutical Industry is Shining a Light on a Rare Cause of Heart Failure
Among the lesser known causes of heart failure is transthyretin amyloid cardiomyopathy (ATTR-CM). Early suspicion and diagnosis are crucial. That’s why Pfizer is working with other industry partners as part of the ASPIRE group, led by Amyloidosis Research Consortium (ARC), to accelerate earlier detection and diagnosis.
Brighter Together: How the Pharmaceutical Industry is Shining a Light on a Rare Cause of Heart Failure
Among the lesser known causes of heart failure is transthyretin amyloid cardiomyopathy (ATTR-CM). Early suspicion and diagnosis are crucial. That’s why Pfizer is working with other industry partners as part of the ASPIRE group, led by Amyloidosis Research Consortium (ARC), to accelerate earlier detection and diagnosis.
You’ve Still Got It: Aging with Agency to Stay on Top of Your Health Year-Round
Aamir Malik is Executive Vice President, Chief U.S. Commercial Officer, Pfizer Inc. Today, he writes about the importance of taking control of your health as you age.
You’ve Still Got It: Aging with Agency to Stay on Top of Your Health Year-Round
Aamir Malik is Executive Vice President, Chief U.S. Commercial Officer, Pfizer Inc. Today, he writes about the importance of taking control of your health as you age.
Developing a Path Forward in Cancer Cachexia
Across disciplines, therapeutic areas, and even continents, Pfizer scientists have been working to advance understanding of – and potential treatments for – cachexia, a complex metabolic condition associated with certain chronic conditions.
Developing a Path Forward in Cancer Cachexia
Across disciplines, therapeutic areas, and even continents, Pfizer scientists have been working to advance understanding of – and potential treatments for – cachexia, a complex metabolic condition associated with certain chronic conditions.